Bafna Pharmaceuticals Q4 Results
- BSE: 532989
- NSE: BAFNAPH
- ISIN: INE878I01022
- Sector: Biotechnology & Drugs
BSE
433.50
8.50 (2.00%)
8.50 (2.00%)Volume2.12 K
Updated: Mon 12 Oct, 2026 | 15:15:00
NSE
426.358.35 (2.00%)
8.35 (2.00%)Volume190.00
Updated: Mon 12 Oct, 2026 | 15:14:40
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Bafna Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 40.35 | 36.81 | 9.64% | 39.78 | 6.33% |
| Depreciation/ Amortization | 1.66 | 1.57 | 5.73% | 1.27 | 671.73% |
| Operating Income | 1.89 | 1.48 | 27.50% | 1.62 | 70.30% |
| Net Income | 2.75 | 1.84 | 49.66% | 1.46 | 109.74% |
| Other Operating Expenses Total | 3.51 | 2.62 | 33.90% | 4.90 | -7.18% |
| Net Income Before Taxes | 2.62 | 1.84 | 42.60% | 1.46 | 99.86% |
| Total Revenue | 42.24 | 38.29 | 10.33% | 41.40 | 8.14% |
| Selling/ General/ Admin Expenses Total | 5.44 | 5.35 | 1.84% | 5.38 | -2.47% |
| Diluted Normalized EPS | 1.11 | 0.78 | 41.97% | 0.62 | -15.75% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.